Crinetics Pharmaceuticals, Inc. (CRNX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16
	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Assets
Cash and equivalents	32.7	200.7	93.1	40.3	45.0	14.2	12.2
Short-term investments	278.6			78.1	118.9
Other current assets	33.9	144.0	84.4	4.9	2.8	1.0	0.2
Total current assets	345.2	344.7	177.5	123.3	166.7	15.2	12.4
Property, plant, and equipment, net	3.5	2.8	3.2	3.9	4.2	0.4	0.2
Other fixed assets	0.0		0.0	0.1		0.0	0.0
Total assets	352.2	351.0	183.4	130.4	171.4	15.6	12.6

Accounts payable	6.9	3.4				0.4	0.3
Accrued expenses				2.1	2.3	0.2	0.5
Current portion of long-term debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Current portion of long-term debt							0.0
Deferred revenues	2.2
Other current liabilities	18.6	12.6	10.5	6.2	5.6	0.3
Total current liabilities	27.7	16.0	10.5	8.3	7.9	0.9	0.9
Long-term debt							0.2
Other liabilities	8.1	3.1	4.0	4.9	3.3	0.0	0.0
Total liabilities	35.8	19.1	14.5	13.2	11.2	0.9	1.1

Shareholders' equity [+]	316.3	331.9	168.9	117.1	160.2	14.7	11.5
Paid-in capital						1.2	0.9
Retained earnings	-439.2	-275.3	-167.6	-93.8	-43.4	-16.3	-7.1
Tangible shareholders' equity	316.3	331.9	168.9	117.1	160.2	14.7	11.5